We are live on ! Find out more
DIA

Denver Investment Advisors Portfolio holdings

AUM $1.89B
1-Year Est. Return 7.9%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+7.9%
3 Year Est. Return
+137.4%
5 Year Est. Return
+240.62%
10 Year Est. Return
AUM
$3.4B
AUM Growth
+$3.4B
Cap. Flow
+$333M
Cap. Flow %
9.77%
Top 10 Hldgs %
11.83%
Holding
710
New
132
Increased
221
Reduced
193
Closed
103

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.56%
2 Financials 14.46%
3 Technology 12.74%
4 Industrials 12.63%
5 Healthcare 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DWSN icon
576
Dawson Geophysical
DWSN
$140M
$131K ﹤0.01%
7,698
+2,635
+52% +$50.8K
EVC icon
577
Entravision Communication
EVC
$1.1B
$131K ﹤0.01%
19,533
+6,685
+52% +$42.4K
ALSK
578
DELISTED
Alaska Communications Systems
ALSK
$128K ﹤0.01%
+66,506
New +$143K
ARRY
579
DELISTED
Array Biopharma Inc
ARRY
$125K ﹤0.01%
26,636
+9,134
+52% +$45.9K
WNEB icon
580
Western New England Bancorp
WNEB
$280M
$124K ﹤0.01%
16,604
+5,683
+52% +$42.4K
POZN
581
DELISTED
POZEN INC
POZN
$123K ﹤0.01%
15,393
+2,896
+23% +$23.7K
MDGL icon
582
Madrigal Pharmaceuticals
MDGL
$11.9B
$122K ﹤0.01%
+809
New +$159K
GSL icon
583
Global Ship Lease
GSL
$1.52B
$119K ﹤0.01%
+3,415
New +$143K
ACLS icon
584
Axcelis
ACLS
$4.26B
$111K ﹤0.01%
12,939
+4,428
+52% +$40.7K
AUDC icon
585
AudioCodes
AUDC
$254M
$110K ﹤0.01%
+15,189
New +$119K
CRDF icon
586
Cardiff Oncology
CRDF
$76.2M
$110K ﹤0.01%
267
+92
+53% +$39.8K
VERU icon
587
Veru
VERU
$38M
$109K ﹤0.01%
1,400
IMMU
588
DELISTED
Immunomedics Inc
IMMU
$103K ﹤0.01%
+24,461
New +$121K
RXII
589
DELISTED
GALENA BIOPHARMA INC COM
RXII
$98K ﹤0.01%
+39,326
New +$98K
ALXA
590
DELISTED
Alexza Pharmaceuticals Inc
ALXA
$92K ﹤0.01%
20,808
+7,122
+52% +$36.5K
ZGNX
591
DELISTED
Zogenix, Inc.
ZGNX
$89K ﹤0.01%
+3,912
New +$127K
CVO
592
DELISTED
Cenevo, Inc.
CVO
$79K ﹤0.01%
3,244
+1,110
+52% +$29.8K
NSPH
593
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$78K ﹤0.01%
+1,812
New +$85.6K
AVNR
594
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$76K ﹤0.01%
+20,776
New +$79.2K
GERN icon
595
Geron
GERN
$962M
$53K ﹤0.01%
+26,586
New +$106K
STSI
596
DELISTED
STAR SCIENTIFIC INC
STSI
$16K ﹤0.01%
20,000
ABR icon
597
Arbor Realty Trust
ABR
$992M
-18,746
Closed -$125
AIT icon
598
Applied Industrial Technologies
AIT
$13.3B
-5,900
Closed -$290
ALGN icon
599
Align Technology
ALGN
$12.1B
-146,756
Closed -$8.39K
AXS icon
600
AXIS Capital
AXS
$7.57B
-10,950
Closed -$521

Similar funds

Denver Investment Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Denver Investment Advisors held 710 positions worth $3.4B, up 96,110% from $3.54M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Denver Investment Advisors deployed $333M of net new capital in Q1 2014, opening 132 new positions and adding to 221 existing holdings. Its largest new stake was Post Properties: 424,390 shares worth $20.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was West Pharmaceutical, an estimated $18.1M trimmed.

  • Denver Investment Advisors's largest Q1 2014 buy was Post Properties: 424,390 shares worth $20.8M.
  • Denver Investment Advisors added most to Magic Software Enterprises in Q1 2014, an estimated $21.4M increase.
  • Denver Investment Advisors's biggest Q1 2014 reduction was West Pharmaceutical, cutting an estimated $18.1M.
  • Denver Investment Advisors fully exited UNS ENERGY CORP COM in Q1 2014, selling an estimated $27.1K.
  • Denver Investment Advisors's ten largest holdings make up 12% of its $3.4B portfolio in Q1 2014.
  • Denver Investment Advisors opened 132 new positions and closed 103 in Q1 2014.
  • Denver Investment Advisors's portfolio value rose 96,110% quarter-over-quarter to $3.4B.

Based on Denver Investment Advisors's 13F filing for Q1 2014, filed 14 May 2014.